Definitive Healthcare Corp. (DH)
NASDAQ: DH · Real-Time Price · USD
1.130
+0.130 (13.06%)
At close: Mar 20, 2026, 4:00 PM EDT
1.090
-0.040 (-3.54%)
After-hours: Mar 20, 2026, 7:55 PM EDT
Definitive Healthcare Stock Forecast
Stock Price Forecast
The 5 analysts that cover Definitive Healthcare stock have a consensus rating of "Hold" and an average price target of $3.43, which forecasts a 203.54% increase in the stock price over the next year. The lowest target is $2.00 and the highest is $6.00.
Price Target: $3.43 (+203.54%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Definitive Healthcare stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +165.49% | Feb 27, 2026 |
| Stephens & Co. | Stephens & Co. | Hold Maintains $3 → $2 | Hold | Maintains | $3 → $2 | +76.99% | Feb 27, 2026 |
| Barclays | Barclays | Sell Maintains $3 → $2.75 | Sell | Maintains | $3 → $2.75 | +143.36% | Dec 9, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +253.98% | Nov 10, 2025 |
| Stifel | Stifel | Strong Buy Maintains $5 → $6 | Strong Buy | Maintains | $5 → $6 | +430.97% | Aug 8, 2025 |
Financial Forecast
Revenue This Year
230.32M
from 241.52M
Decreased by -4.64%
Revenue Next Year
231.01M
from 230.32M
Increased by 0.30%
EPS This Year
0.21
from -1.30
EPS Next Year
0.23
from 0.21
Increased by 9.88%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 237.0M | 243.7M | |
| Avg | 230.3M | 231.0M | |
| Low | 216.6M | 214.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.9% | 5.8% | |
| Avg | -4.6% | 0.3% | |
| Low | -10.3% | -6.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.28 | 0.30 | |
| Avg | 0.21 | 0.23 | |
| Low | 0.16 | 0.15 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 45.2% | |
| Avg | - | 9.9% | |
| Low | - | -29.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.